Quantres Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$2.3M Buy
8,000
+6,200
+344% +$1.79M 1.66% 11
2018
Q4
$473K Buy
+1,800
New +$495K 0.29% 118
2018
Q3
Sell
-1,000
Closed -$238K 227
2018
Q2
$238K Buy
+1,000
New +$232K 0.14% 173
2018
Q1
Sell
-3,900
Closed -$878K 179
2017
Q4
$878K Buy
+3,900
New +$831K 0.55% 64
2016
Q4
Sell
-4,900
Closed -$614K 182
2016
Q3
$614K Buy
+4,900
New +$633K 0.38% 95
2016
Q2
Sell
-3,100
Closed -$431K 189
2016
Q1
$431K Buy
+3,100
New +$414K 0.41% 73
2014
Q3
Sell
-2,400
Closed -$258K 175
2014
Q2
$258K Buy
+2,400
New +$247K 0.29% 124

Other funds holding ELV

Quantres Asset Management's ELV Position: Q1 2019 in Review

Quantres Asset Management increased its Elevance Health (ELV) stake by 344% in Q1 2019, buying an estimated $1.79M and bringing the position to 8,000 shares worth $2.3M. The position accounts for 1.66% of the portfolio, ranked #11.

Quantres Asset Management first reported a position in ELV in Q2 2014 and has held it in 7 quarters since. 1,075 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Quantres Asset Management held 8,000 shares of Elevance Health worth $2.3M as of Q1 2019.
  • Quantres Asset Management bought 6,200 Elevance Health shares in Q1 2019, an estimated $1.79M.
  • Elevance Health made up 1.66% of Quantres Asset Management's portfolio in Q1 2019, its #11 holding.
  • Quantres Asset Management first reported a position in Elevance Health in Q2 2014 and has held it in 7 quarters since.
  • 1,075 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Quantres Asset Management's 13F filing for Q1 2019, filed 12 Apr 2019.